WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 39 filers reported holding WEREWOLF THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,783 | -29.8% | 26,067 | 0.0% | 0.00% | – |
| Q2 2023 | $79,504 | +53.6% | 26,067 | +31.0% | 0.00% | – |
| Q1 2023 | $51,756 | +36.9% | 19,906 | +8.0% | 0.00% | – |
| Q4 2022 | $37,800 | -55.0% | 18,439 | -0.6% | 0.00% | – |
| Q3 2022 | $84,000 | +47.4% | 18,553 | +34.3% | 0.00% | – |
| Q2 2022 | $57,000 | -93.4% | 13,818 | -92.9% | 0.00% | – |
| Q1 2022 | $859,000 | -64.0% | 195,068 | -2.5% | 0.00% | – |
| Q4 2021 | $2,383,000 | +97.3% | 200,065 | +184.2% | 0.00% | – |
| Q3 2021 | $1,208,000 | -8.6% | 70,404 | -7.1% | 0.00% | – |
| Q2 2021 | $1,322,000 | – | 75,774 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,796,761 | 38.27% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $13,066,725 | 6.41% |
| MPM BioImpact LLC | 2,388,011 | $7,283,434 | 1.47% |
| RA Capital Management | 6,144,881 | $18,741,887 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,911,771 | 0.30% |
| PFM Health Sciences, LP | 2,303,891 | $7,026,868 | 0.27% |
| Rubric Capital Management LP | 1,935,357 | $5,902,839 | 0.25% |
| Alyeska Investment Group, L.P. | 397,808 | $1,213,314 | 0.01% |
| Laurion Capital Management LP | 522,900 | $1,594,845 | 0.01% |
| Schonfeld Strategic Advisors LLC | 326,702 | $996,441 | 0.01% |